期刊文献+

非垂体降调节促排卵方案在卵巢储备功能正常患者IVF-ET/ICSI中的应用 被引量:2

下载PDF
导出
摘要 目的:探讨非垂体降调节促排卵方案在卵巢储备功能正常的不孕患者IVFET/ICSI中的应用价值。方法:接受IVF-ET/ICSI助孕的卵巢储备功能正常的不孕症患者共200例,根据促排卵方案分为两组:非垂体降调节组(非降调节组)98个周期,GnRH-a长方案组(长方案组)102个周期,比较两组的Gn时间、Gn量、平均获卵数、卵裂率、优胚率、可利用胚胎率、临床妊娠率、种植率、冷冻胚胎周期率等各项指标。结果:非降调节组的获卵数、MⅡ卵数低于长方案组,优胚率及可利用胚率明显高于长方案组,差异均有统计学意义(P<0.05)。非降调节组的鲜胚移植临床妊娠率为51.7%,略低于长方案组的54.5%,但差异无统计学意义。非降调节组在h CG注射日前持续性高LH(LH≥10m IU/ml)者共有9例,其胚胎种植率为30%,临床妊娠率为60%。结论:对于卵巢储备功能正常的不孕症患者,非降调节促排卵方案能明显提高优胚率,且鲜胚移植的临床妊娠率与长方案组无明显差异。非降调节组中持续性高LH不会影响胚胎的种植率及临床妊娠率。
出处 《现代妇产科进展》 CSCD 北大核心 2015年第9期693-696,共4页 Progress in Obstetrics and Gynecology
  • 相关文献

参考文献13

  • 1Bodri D, Kawachiya S, De Brucker M, et al. Cumulative success rates following mild IVF in unselected infertile patients a 3-year, single-centre cohort study. [ J ]. Reprod BioMed Online ,2014,28 (5) :572-581.
  • 2何雯,匡延平.微刺激条件下高血黄体生成素水平对于多囊卵巢综合征患者IVF结局影响的病例对照研究[J].生殖医学杂志,2014,23(3):214-218. 被引量:12
  • 3Abdel Mohsen I, Ezz E1 Din R. Minimal stimulation proto- col using letrozole versus microdose flare up GnRH ago- nist protocol in women with poor ovarian response under- going ICSI [ J ]. Gynecol Endocrinol, 2012,29 ( 2 ) : 105- 108.
  • 4匡延平.非降调节促排卵中高LH水平现象不等于卵子损害[R].优化的辅助生殖技术国际研讨会,2014,33-36.
  • 5Grabia A, Papier S, Pesce R, et al. Preliminary experience with a low-cost stimulation protocol that includes letrozole and human menopausal gonadotropins in normal respond- ers for assisted reproductive technologies [ J ]. Fertil Ster- il,2006,86 (4) : 1026-1028.
  • 6Ozdemir U, Ozaksit G, Gungor AN, et al. Letrozole usage adjuvant to gonadotropins for ovulation induction for pa-tients with clomiphene citrate failure [ J ]. Arch Gynecol Obstet, 2013,288 ( 2 ) : 445-448.
  • 7Casper RF, Mitwally MF. Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome [ J ]. Clin Obstet Gyneeol, 2011,54 (4) : 685-695.
  • 8曹蓓,李艳萍,刘冬娥,刘能辉,张琼,郝洁,朱琳.微刺激方案与常规促排卵方案在高龄卵巢低反应不育女性中的前后周期比较[J].生殖医学杂志,2014,23(9):709-713. 被引量:17
  • 9陈碧娟,伍琼芳,许定飞,聂玲.短方案和微刺激方案在卵巢低反应助孕患者中的应用研究[J].中国妇产科临床杂志,2011,12(6):422-424. 被引量:4
  • 10Legro RS, Kunselman Brzyski RG, et al. The Pregnancy in Polycystic Ovary Syndrome II (PPCOSII) trial : Ration- ale and design of a double-blind randomized trial of clomiphene citrate and letrozole for the treatment of in- fertility in women with polycystic ovary syndrome [ J ]. Contemporary Clin Trials, 2012,33 ( 3 ) :470-481.

二级参考文献60

共引文献33

同被引文献14

  • 1Eppig JJ. Maintenance of meiotic arrest and induction of oocyte maturation in mouse oocyte-granulosa cell complexes developed in vitro fTom preantral follicles. Biol Reprod,1991, 45(6):824-30.
  • 2Gilchrist RB, Lane M, Thompson JG. Oocyte-secreted factors: regulators of cumulus cell function and oocyte quality. Hum Reprod Update, 2008, 14(2): 159-77.
  • 3Kenigsberg S, Bentov Y, Chalifa-Caspi V, et al. Gene expression microarray profiles of cumulus cells in lean and overweight obese polycystic ovary syndrome patients. Mol Hum Reprod, 2009, 15(2):89-103.
  • 4Li R, Norman RJ, Armstrong DT, et al. Oocyte-secreted factor(s) determine functional differences between bovine mural granu- losa cells and cumulus cells. Biol Reprod, 2000, 63:839-45.
  • 5Yeo CX, Gilchrist RB, Thompson JG, et al. Exogenous growth differentiation factor 9 in oocyte maturation media enhances subsequent embryo development and fetal viability inmice. Hum Reprod, 2008, 23(1):67-73.
  • 6Vitt UA~ Hayashi M, Klein C, et al. Growth differentiation factor-9 stimulates proliferation but suppresses the follicle- stimulating hormone-induced differentiation of cultured granu- losa cells from small antral and preovulatory rat follicles. Biol Reprod, 2000, 62(2):330-7.
  • 7Juengel JL, Mcnatty KP. The role of pruteins ot the transforming growth factor-beta superfamily in the intraovarian regulation of follicular development. Hum Reprod Update, 2005, 11(2): 143-60.
  • 8Moore RK, Shimasaki S. Molecular biology and physiological role of the oocyte factor, BMP-15. Mol Cell Endocrinol,2005, 234(1-2):67-73.
  • 9Revelli A, Casano S, Salvaqno F, et al. Milder is better? advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization. Reprod Biol Endocrinol, 201 I, 9(1):25.
  • 10匡延平,于莎,洪青青.超排卵中晚期克罗米芬防止黄体生成素峰的研究[J].生殖医学杂志,2010,19(A01):13-17. 被引量:16

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部